Navitas Stock Soars 110% on AI Hype, but Valuation Hits 74x Sales as Revenue Remains Elusive

What happened

Navitas Semiconductor shares have surged 110% in under four months, pushing its price-to-sales ratio to an extraordinary 74.3x, as the market prices in rapid adoption of its GaN and SiC power devices in AI data centers. However, the company's latest filings reveal that this revenue inflection remains unproven: Q4 2025 revenue was just $7.3 million, operating losses were $41.4 million, and management's own risk factors warn that the strategic pivot to AI infrastructure may not achieve anticipated results. The DeepValue Master Report assigns a WAIT rating with an attractive entry of $6.50, implying that the current price embeds a rich premium for future design wins that have not yet materialized. Key near-term proof points include sequential revenue growth in Q1 and Q2 2026, and disclosure of named AI data-center design wins with revenue timing. Without these catalysts, the elevated valuation leaves the stock vulnerable to a sharp re-rating, especially given the company's history of equity dilution and ongoing cash burn.

Implication

Navitas's 74.3x price-to-sales ratio reflects a market narrative that the company will soon become a key supplier for NVIDIA's 800V data-center architecture. However, the company's own filings and the master report indicate that revenue conversion is still early stage, with Q4 2025 revenue declining and significant operating losses. The WAIT rating with a $6.50 attractive entry suggests a roughly 30% downside from current levels, with the risk-reward favoring patience. Investors should demand two consecutive quarters of sequential revenue growth and a named design win before paying a premium for future growth. Without these milestones, the stock is likely to correct as the narrative fades and dilution risks materialize.

Thesis delta

The recent 110% surge has widened the gap between price and fundamental progress. The market is now pricing in success on AI data-center penetration, but the master report's bear case of deferred purchases into 2027 and renewed dilution becomes more likely if Q1 2026 revenue disappoints. The thesis shifts from 'wait for proof points' to 'wait for proof points at an even more expensive entry,' increasing the importance of the Q1 2026 earnings report.